The Effect of Art Therapy on Patients With Stroke
|ClinicalTrials.gov Identifier: NCT04038424|
Recruitment Status : Recruiting
First Posted : July 30, 2019
Last Update Posted : November 19, 2019
|Condition or disease||Intervention/treatment||Phase|
|Ischemic Stroke and Hemorrhagic Stroke||Other: Art therapy||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||60 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||The Effect of Art Therapy on Cognitive Ability, Arm Activity and Mental Health Status in Patients With Stroke|
|Actual Study Start Date :||September 20, 2019|
|Estimated Primary Completion Date :||April 2020|
|Estimated Study Completion Date :||September 2020|
Experimental: Study group
The intervention group (n = 30) will receive Routine Hospital Management (RHM), conventional rehabilitation activity and AT (painting, coloring, listening to music and Hand Therapy Ball Exercises). Overall 9 sessions over a period of three weeks will be performed and each session will take around 30 min.
Other: Art therapy
Art therapy including coloring, painting and listening to music
Other Name: Hand Therapy Ball Exercises
No Intervention: Control group
The control group (n = 30) will receive only the Routine Hospital Management (RHM) and the department conventional rehabilitation activity.
- The Montreal Cognitive Assessment (MOCA) [ Time Frame: 3 weeks ]The Montreal Cognitive Assessment is a 16-item screening assessment for mild cognitive impairment. It is widely used in stroke survivors and assesses performance attention, concentration, executive functions, memory, language, visual-constructional skills, conceptual thinking, calculations and orientation. The maximum score is 30 and scores of under 26 indicate cognitive impairment.
- The Hospital Anxiety and Depression Scale (HADS) [ Time Frame: 3 weeks ]This measurement consists of two subscales: Anxiety subscale (HADS-A) and a depression subscale (HADS-D) with 14 intermingled items. Each item is rated on a four-point scale of 0-3, giving maximum scores of 21 for anxiety and depression respectively. Scores of 11 or more on either subscale are considered as significant 'case' of psychological comorbidity, a score of 8-10 as borderline while a score of 7 or below is considered as normal.
- The Arm Activity (ArmA) Measure [ Time Frame: 3 weeks ]The ArmA measure is a patient and/or career-reported 20-item measure of difficulty in passive and active hemiparetic arm function. It consists of a seven-item passive function subscale, and 13-item active function subscale. Using a Likert scoring system between zero (no difficulty) and four (unable to do task). The passive function subscale scores range from zero (high function) to 28 and the active function subscale scores range from zero (high function) to 52.
- The Roger's Happy Sad face [ Time Frame: pre and post each session/3 weeks ]This Roger's scale will be used to assess mood, anxiety, and pain. The score ranges from 0-4, with 0 ''no symptoms'', and 4 ''worst possible symptoms''.
- Self-efficacy and satisfaction for Art [ Time Frame: 3 weeks ]To assess self-efficacy and perceived difficulty for art expression we will ask two single item questions. a four-point visual analogue scale with one as least confident/difficult and four as most confident/difficult. Additional question will be asked to rate the participant satisfaction with the intervention as a supportive method during their treatment.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04038424
|Contact: Naglaa F Youssef, PhDemail@example.com|
|Contact: Naglaa F Youssef, PhDfirstname.lastname@example.org|
|Unit of stroke and cerebral vascular disease treatment||Recruiting|
|Contact: Ahmed Abdelalem, Professor|